Stocks To Buy Now

Blog


Fresh Promise Foods, Inc. (FPFI) Engages QualityStocks Investor Relations Services

Fresh Promise Foods, a Georgia-based natural and organic health and wellness company and innovator of the world’s first USDA organic, Non-GMO Project verified chewable juice, announced today that it has engaged the investor relations services of QualityStocks. Based in Scottsdale, Arizona, QualityStocks has assisted more than 300 public companies with their efforts to broaden influence, attract growth capital and improve shareholder value.

“We’ve been on the fast-track since launching our chewable products online in December 2014, expanding our market presence — including distribution through Whole Foods Markets — and exploring further product development,” stated Kevin Quirk, CEO of Fresh Promise Foods. “As we maintain this momentum, we want to ensure that our consumer brand, products and progress are clearly communicated to shareholders and the broader public. We look forward to partnering with QualityStocks to achieve this goal.”

Experts at communication efficiency and brand visibility, QualityStocks will leverage its vast network of partners, daily and weekly newsletters, social media channels, blog and other outreach tools to elevate market awareness of Fresh Promise Foods, its Harvest Soul subsidiary, and the company’s advancing position in the health and wellness food and beverage sector.

“Our strategy is to work closely with Fresh Promise Foods and Harvest Soul to help investors understand the business model and market potential in the $35 billion U.S. organic food and beverage sector,” stated QualityStocks Managing Director Michael McCarthy. “The QualityStocks team will leverage nearly a decade of experience with our vast distribution network to put this growing consumer brand on the map.”

For more information, visit www.freshpromisefoods.com

Let us hear your thoughts: Fresh Promise Foods, Inc. Message Board

From Our Blog

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Is Focused on Vision for Personalized Heart Care

May 18, 2026

CDIO’s vision reflects a broader shift taking place across the healthcare industry toward predictive and Precision Medicine. Achieving that goal requires a combination of scientific expertise, advanced technology, scalable testing and improved accessibility. Cardio Diagnostics’ focus on innovation is particularly relevant in cardiovascular disease, where earlier identification of risk factors can significantly influence outcomes. Heart […]

Rotate your device 90° to view site.